AMGEN Inc. (NASDAQ: AMGN) is 17.14% higher on its value in year-to-date trading and has touched a low of $249.70 and a high of $346.85 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AMGN stock was last observed hovering at around $335.95 in the last trading session, with the day’s gains setting it 1.43%.
Currently trading at $337.38, the stock is 2.36% and 2.47% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.07 million and changing 0.43% at the moment leaves the stock 11.93% off its SMA200. AMGN registered 24.28% gain for a year compared to 6-month gain of 21.82%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.50% loss in the last 1 month and extending the period to 3 months gives it a 9.48%, and is 1.48% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.50% over the week and 1.83% over the month.
AMGEN Inc. (AMGN) has around 26700 employees, a market worth around $181.28B and $30.74B in sales. Current P/E ratio is 58.13 and Fwd P/E is 16.19. Profit margin for the company is 10.18%. Distance from 52-week low is 35.11% and -2.73% from its 52-week high. The company has generated returns on investments over the last 12 months (4.96%).
with sales reaching $8.52B over the same period.The EPS is expected to grow by 4.71% this year, but quarterly earnings will post 26.00% year-over-year. Quarterly sales are estimated to grow 23.50% in year-over-year returns.
AMGEN Inc. (AMGN) Top Institutional Holders
3557.0 institutions hold shares in AMGEN Inc. (AMGN), with institutional investors hold 81.31% of the company’s shares. The shares outstanding are 537.33M, and float is at 536.01M with Short Float at 1.58%. Institutions hold 81.10% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 51.87 million shares valued at $16.21 billion. The investor’s holdings represent 9.6779% of the AMGN Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 46.04 million shares valued at $14.39 billion to account for 8.5901 of the shares outstanding. The other top investors are STATE STREET CORP which holds 28.97 million shares representing 5.4051% and valued at over $9.05 billion, while PRIMECAP MANAGEMENT CO/CA/ holds 2.6954 of the shares totaling 14.45 million with a market value of $4.51 billion.
AMGEN Inc. (AMGN) Insider Activity
The most recent transaction is an insider sale by Grygiel Nancy A., the company’s SVP & CCO. SEC filings show that Grygiel Nancy A. sold 2,117 shares of the company’s common stock on May 03 ’24 at a price of $313.09 per share for a total of $0.66 million. Following the sale, the insider now owns 9883.0 shares.
AMGEN Inc. disclosed in a document filed with the SEC on Dec 04 ’23 that Grygiel Nancy A. (SVP & CCO) sold a total of 2,096 shares of the company’s common stock. The trade occurred on Dec 04 ’23 and was made at $273.03 per share for $0.57 million. Following the transaction, the insider now directly holds 10874.0 shares of the AMGN stock.
Still, SEC filings show that on Nov 08 ’23, Graham Jonathan P (EVP, Gen. Counsel & Secy.) disposed off 10,000 shares at an average price of $272.81 for $2.73 million. The insider now directly holds 28,078 shares of AMGEN Inc. (AMGN).
